183 related articles for article (PubMed ID: 9284891)
1. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
[TBL] [Abstract][Full Text] [Related]
2. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
[TBL] [Abstract][Full Text] [Related]
3. Significance of guanidino compounds in non-dialyzed patients with chronic renal failure.
Ikezaki N
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):283-90. PubMed ID: 2355664
[TBL] [Abstract][Full Text] [Related]
4. Serum guanidino compound levels and clearances in uremic patients treated with continuous ambulatory peritoneal dialysis.
De Deyn PP; Marescau B; Swartz RD; Hogaerth R; Possemiers I; Lowenthal A
Nephron; 1990; 54(4):307-12. PubMed ID: 2325795
[TBL] [Abstract][Full Text] [Related]
5. Guanidino compounds in serum and cerebrospinal fluid of non-dialyzed patients with renal insufficiency.
De Deyn PP; Marescau B; Cuykens JJ; Van Gorp L; Lowenthal A; De Potter WP
Clin Chim Acta; 1987 Jul; 167(1):81-8. PubMed ID: 3665089
[TBL] [Abstract][Full Text] [Related]
6. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
[TBL] [Abstract][Full Text] [Related]
7. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.
Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R
Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113
[TBL] [Abstract][Full Text] [Related]
8. Guanidino compounds in uraemic dialysed patients.
De Deyn P; Marescau B; Lornoy W; Becaus I; Lowenthal A
Clin Chim Acta; 1986 Jun; 157(2):143-50. PubMed ID: 3719996
[TBL] [Abstract][Full Text] [Related]
9. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Levillain O; Marescau B; de Deyn PP
Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
[TBL] [Abstract][Full Text] [Related]
10. [Chronic renal failure and guanidino compounds].
Kinoshita T
Yakugaku Zasshi; 1997 Nov; 117(10-11):673-80. PubMed ID: 9414581
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
[TBL] [Abstract][Full Text] [Related]
12. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
[TBL] [Abstract][Full Text] [Related]
13. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction.
Verhelst J; Berwaerts J; Marescau B; Abs R; Neels H; Mahler C; De Deyn PP
Metabolism; 1997 Sep; 46(9):1063-7. PubMed ID: 9284897
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
Sawynok J; Dawborn JK
Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
[TBL] [Abstract][Full Text] [Related]
15. Guanidino compounds in serum and urine of cirrhotic patients.
Marescau B; De Deyn PP; Holvoet J; Possemiers I; Nagels G; Saxena V; Mahler C
Metabolism; 1995 May; 44(5):584-8. PubMed ID: 7752905
[TBL] [Abstract][Full Text] [Related]
16. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
Suzuki Y
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
[TBL] [Abstract][Full Text] [Related]
17. NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency.
Al Banchaabouchi M; Marescau B; Possemiers I; D'Hooge R; Levillain O; De Deyn PP
Pflugers Arch; 2000 Mar; 439(5):524-31. PubMed ID: 10764210
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and histopathological changes in nephrectomized mice.
Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP
Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577
[TBL] [Abstract][Full Text] [Related]
19. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
[TBL] [Abstract][Full Text] [Related]
20. Liquid-chromatographic determination of guanidino compounds in plasma and erythrocyte of normal persons and uremic patients.
Kikuchi T; Orita Y; Ando A; Mikami H; Fujii M; Okada A; Abe H
Clin Chem; 1981 Nov; 27(11):1899-902. PubMed ID: 7296840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
